M&A Deal Summary |
|
|---|---|
| Date | 2025-12-16 |
| Target | PharmaCann Colorado Retail Assets |
| Sector | Agriculture |
| Buyer(s) | Vireo Growth |
| Sellers(s) | PharmaCann |
| Deal Type | Divestiture |
| Deal Value | 49M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2004 |
| Sector | Agriculture |
| Employees | 419 |
| Revenue | 99M USD (2024) |
Vireo Growth is a science-focused, multi-state cannabis company. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. Vireo Growth was founded in 2004 and is based in Minneapolis, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector: Agriculture M&A | 3 of 3 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Colorado M&A | 1 of 1 |
| Country: United States M&A | 5 of 5 |
| Year: 2025 M&A | 2 of 2 |
| Size (of disclosed) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-06-05 |
Proper Brands
St. Louis, Missouri, United States Proper Brands is a fully vertical cannabis company focused on growing quality cannabis and building premium brands aimed at providing personalized experiences for every individual, paired with exceptional customer service and support. Proper Brands is based in St. Louis, Missouri. |
Buy | $102M |
PharmaCann LLC is a medical cannabis providers, cultivates, processes and dispenses safe, independently tested cannabis products to improve people’s lives. PharmaCann’s dispensaries, called Verilife, and production facilities, called Veriplant, are operating in multiple states including Illinois, Maryland, Massachusetts and New York, with other locations in development including Michigan, Ohio, Pennsylvania and Virginia.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Agriculture M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Colorado M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |